CIAS
CHINA SCORE INC
stock OTC

Thanks for sharing the video. I’m cautiously bullish on ATAI.
It’s not easy to get a drug all the way through to FDA approval, and the ATAI narrative is very much built on them being a “portfolio company” — ie, them getting several drugs to market.
I think they initially had five (5) drugs in the portfolio. PCN-101 and their CIAS drug failed to meet primary endpoints, so now we’re down to three candidates: BPL, VLS, EMP.
IMO, they REALLY need VLS to deliver the goods. If VLS doesn’t make it through the pipe then ATAI risks starting to look like a one trick pony with BPL.
Who knows about R-MDMA, just way too soon for that one.
So yeh, $30-50B in market cap? Sure, I would love that. But that would essentially entail a flawless execution from here on out with all remaining drugs succeeding. Statistically unlikely but I’m here for it 😅

Thanks for sharing the video. I’m cautiously bullish on ATAI.
It’s not easy to get a drug all the way through to FDA approval, and the ATAI narrative is very much built on them being a “portfolio company” — ie, them getting several drugs to market.
I think they initially had five (5) drugs in the portfolio. PCN-101 and their CIAS drug failed to meet primary endpoints, so now we’re down to three candidates: BPL, VLS, EMP.
IMO, they REALLY need VLS to deliver the goods. If VLS doesn’t make it through the pipe then ATAI risks starting to look like a one trick pony with BPL.
Who knows about R-MDMA, just way too soon for that one.
So yeh, $30-50B in market cap? Sure, I would love that. But that would essentially entail a flawless execution from here on out with all remaining drugs succeeding. Statistically unlikely but I’m here for it 😅